Thermo Fisher Scientific Expands Pharma Division in Greenville, North Carolina
03/20/2019
According to company officials the expansion will provide additional capacity for sterile liquid and lyophilized product development and commercial manufacturing.
Included in the site expansion projects are Monza and Ferentino, Italy, and Greenville, North Carolina. In response to customer requests, each of the sites will be equipped with aseptic filling lines and isolator technology. Construction is expected to be completed within the next 24 months.
"These investments will help expand our global sterile manufacturing network and meet the increasing demand from customers that rely on our biologics development and manufacturing expertise," said Michel Lagarde, President of pharma services for Thermo Fisher Scientific.
"We continue to invest to expand our capabilities and help our customers deliver the highest quality medicines to the patients who need them,” Lagarde added.
Most Read
-
-
How Is the Pandemic Affecting Location Decisions in the Food & Beverage Industry?
Q2 2020
-
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
Q4 2019
-
COVID-19 Will Remake How We Work and Live
Q2 2020
-
A “Now, Next, Later” Approach for Dealing with Pandemic Challenges
Q2 2020
-
The Future of Manufacturing Site Selection is Connected
Q2 2020
-
“Future-Proofing” Corporate Location Decisions in Uncertain Times
Q2 2020